{"url_path":"/sec/rajaf/10-k/2026/item-16b","section_key":"item-16b","section_title":"Item 16B Code of Ethics**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1885680/0001213900-26-057774-index.html","accession_number":"0001213900-26-057774","cik":"0001885680","ticker":"RAJAF","issuer_name":"Cordyceps Sunshine Biotech Holdings Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1885680/0001213900-26-057774-index.html","primary_entity_key":"0001885680","primary_entity_name":"Cordyceps Sunshine Biotech Holdings Co., Ltd."},"word_count":42,"has_tables":true,"body_markdown":"**Item\n16B. Code of Ethics**\n\n \n\nThe Company has adopted a Code of Business Conduct\nand Ethics that applies to the Company’s directors, officers, employees and advisors. The Code of Business Conduct and Ethics is\nattached as an exhibit to this annual report."}